|
|
|
|
|
|
The 3 Cs You Should Expect From Your Pharma Service Provider | White Paper | By Yves Massicotte, Ropack Pharma Solutions | We share important factors to consider when weighing your contract service provider options. These “Three Cs” can indicate whether a service provider has the capabilities desired by a drug sponsor. |
|
|
|
|
|
By Louis Garguilo, chief editor, Outsourced Pharma | Let’s be honest: for professionals at CDMOs, dealing with university-based clients can feel like trying to run a development campaign through a distortion field. Even when inventors are “spun out” into the “real world” as a biotech, breaking through to the realities of progressing molecules is tricky. Apologies to those who might take offense, but stick with us, this will prove helpful for academia and others to optimize working with CDMOs. | |
|
|
|
INDUSTRY INSIGHTS CONTINUED |
|
|
|
|
'Ultra High' Potency Development And Manufacture | Case Study | Cambrex | A biotech with limited experience in the development and manufacture of high potency compounds sought to develop a process for producing a highly potent API used to treat an unmet oncology need. |
|
|
|
|
| Join 1,000+ pharma, biotech, and drug delivery professionals at the PODD: Partnership Opportunities in Drug Delivery Conference, October 27–28 in Boston. Featuring 10 technology tracks, pharma company spotlights, 1:1 partnering, and more. Attendees will also hear from leaders at companies including AbbVie, Amgen, AstraZeneca, Biogen, Eli Lilly, GSK, Moderna, Novartis, Pfizer, Regeneron, Roche, Sanofi, Takeda, and others. Register at PODDConference.com with code LSL20 for 20% off. |
|
|
|
Regulatory Starting Materials (RSMs) — India | Pharma Expanse | Our network spans nine manufacturing sites across five countries and can support discovery, preclinical, clinical, and commercial programs for New Chemical Entities (NCEs). |
|
|
Formulation And Manufacturing Equipment | AustinPx | We offer integrated GMP manufacturing services for oral dosage forms, complemented by a full range of analytical development and testing capabilities. |
|
|
|
|
OUTSOURCED PHARMA CAPACITY UPDATE |
|
|
|
CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capacities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs. |
|
|
| Connect With Outsourced Pharma: |
|
|
|
